130 related articles for article (PubMed ID: 21837779)
1. The interleukin 6 receptor is a direct transcriptional target of E2F3 in prostate tumor derived cells.
Libertini SJ; Chen H; al-Bataina B; Koilvaram T; George M; Gao AC; Mudryj M
Prostate; 2012 May; 72(6):649-60. PubMed ID: 21837779
[TBL] [Abstract][Full Text] [Related]
2. Role of E2F3 expression in modulating cellular proliferation rate in human bladder and prostate cancer cells.
Olsson AY; Feber A; Edwards S; Te Poele R; Giddings I; Merson S; Cooper CS
Oncogene; 2007 Feb; 26(7):1028-37. PubMed ID: 16909110
[TBL] [Abstract][Full Text] [Related]
3. MiR-377 targets E2F3 and alters the NF-kB signaling pathway through MAP3K7 in malignant melanoma.
Zehavi L; Schayek H; Jacob-Hirsch J; Sidi Y; Leibowitz-Amit R; Avni D
Mol Cancer; 2015 Mar; 14():68. PubMed ID: 25889255
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-6 trans-signalling differentially regulates proliferation, migration, adhesion and maspin expression in human prostate cancer cells.
Santer FR; Malinowska K; Culig Z; Cavarretta IT
Endocr Relat Cancer; 2010 Mar; 17(1):241-53. PubMed ID: 19966016
[TBL] [Abstract][Full Text] [Related]
5. An Rb family-independent E2F3 transcription factor variant impairs STAT5 signaling and mammary gland remodeling during pregnancy in mice.
Liao Y; Du W
J Biol Chem; 2018 Mar; 293(9):3156-3167. PubMed ID: 29330306
[TBL] [Abstract][Full Text] [Related]
6. Evidence that Igf2 down-regulation in postnatal tissues and up-regulation in malignancies is driven by transcription factor E2f3.
Lui JC; Baron J
Proc Natl Acad Sci U S A; 2013 Apr; 110(15):6181-6. PubMed ID: 23530192
[TBL] [Abstract][Full Text] [Related]
7. Tripartite motif containing 28 (Trim28) can regulate cell proliferation by bridging HDAC1/E2F interactions.
Chen L; Chen DT; Kurtyka C; Rawal B; Fulp WJ; Haura EB; Cress WD
J Biol Chem; 2012 Nov; 287(48):40106-18. PubMed ID: 23060449
[TBL] [Abstract][Full Text] [Related]
8. Dexamethasone enhances expression of membrane and soluble interleukin-6 receptors by prostate carcinoma cell lines.
Mori S; Murakami-Mori K; Bonavida B
Anticancer Res; 1998; 18(6A):4403-8. PubMed ID: 9891500
[TBL] [Abstract][Full Text] [Related]
9. Antitumor effects of interleukin-6 (IL-6)/interleukin-6 receptor (IL-6R) signaling pathway inhibition in clear cell carcinoma of the ovary.
Yanaihara N; Hirata Y; Yamaguchi N; Noguchi Y; Saito M; Nagata C; Takakura S; Yamada K; Okamoto A
Mol Carcinog; 2016 May; 55(5):832-41. PubMed ID: 25856562
[TBL] [Abstract][Full Text] [Related]
10. [miR-503-5p inhibits the proliferation of T24 and EJ bladder cancer cells by interfering with the Rb/E2F signaling pathway].
Li X; Han X; Yang J; Sun J; Wei P
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2017 Oct; 33(10):1360-1364. PubMed ID: 29169421
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-6 (IL-6) and/or soluble IL-6 receptor down-regulation of human type II collagen gene expression in articular chondrocytes requires a decrease of Sp1.Sp3 ratio and of the binding activity of both factors to the COL2A1 promoter.
Porée B; Kypriotou M; Chadjichristos C; Beauchef G; Renard E; Legendre F; Melin M; Gueret S; Hartmann DJ; Malléin-Gerin F; Pujol JP; Boumediene K; Galéra P
J Biol Chem; 2008 Feb; 283(8):4850-65. PubMed ID: 18065760
[TBL] [Abstract][Full Text] [Related]
12. Transcription Factor E2F3a in Nucleus Accumbens Affects Cocaine Action via Transcription and Alternative Splicing.
Cates HM; Heller EA; Lardner CK; Purushothaman I; Peña CJ; Walker DM; Cahill ME; Neve RL; Shen L; Bagot RC; Nestler EJ
Biol Psychiatry; 2018 Aug; 84(3):167-179. PubMed ID: 29397901
[TBL] [Abstract][Full Text] [Related]
13. ATR-CHK1-E2F3 signaling transactivates human ribonucleotide reductase small subunit M2 for DNA repair induced by the chemical carcinogen MNNG.
Gong C; Liu H; Song R; Zhong T; Lou M; Wang T; Qi H; Shen J; Zhu L; Shao J
Biochim Biophys Acta; 2016 Apr; 1859(4):612-26. PubMed ID: 26921499
[TBL] [Abstract][Full Text] [Related]
14. E2f3a and E2f3b make overlapping but different contributions to total E2f3 activity.
Danielian PS; Friesenhahn LB; Faust AM; West JC; Caron AM; Bronson RT; Lees JA
Oncogene; 2008 Nov; 27(51):6561-70. PubMed ID: 18663357
[TBL] [Abstract][Full Text] [Related]
15. A novel LncRNA transcript, RBAT1, accelerates tumorigenesis through interacting with HNRNPL and cis-activating E2F3.
He X; Chai P; Li F; Zhang L; Zhou C; Yuan X; Li Y; Yang J; Luo Y; Ge S; Zhang H; Jia R; Fan X
Mol Cancer; 2020 Jul; 19(1):115. PubMed ID: 32669100
[TBL] [Abstract][Full Text] [Related]
16. Circular RNA (circ-0075804) promotes the proliferation of retinoblastoma via combining heterogeneous nuclear ribonucleoprotein K (HNRNPK) to improve the stability of E2F transcription factor 3 E2F3.
Zhao W; Wang S; Qin T; Wang W
J Cell Biochem; 2020 Jul; 121(7):3516-3525. PubMed ID: 32065448
[TBL] [Abstract][Full Text] [Related]
17. Inactivation of the Rb pathway and overexpression of both isoforms of E2F3 are obligate events in bladder tumours with 6p22 amplification.
Hurst CD; Tomlinson DC; Williams SV; Platt FM; Knowles MA
Oncogene; 2008 Apr; 27(19):2716-27. PubMed ID: 18037967
[TBL] [Abstract][Full Text] [Related]
18. IL-6 and sIL-6R induces STAT3-dependent differentiation of human VSMCs into osteoblast-like cells through JMJD2B-mediated histone demethylation of RUNX2.
Kurozumi A; Nakano K; Yamagata K; Okada Y; Nakayamada S; Tanaka Y
Bone; 2019 Jul; 124():53-61. PubMed ID: 30981888
[TBL] [Abstract][Full Text] [Related]
19. E2f3 in tumor macrophages promotes lung metastasis.
Trikha P; Sharma N; Pena C; Reyes A; Pécot T; Khurshid S; Rawahneh M; Moffitt J; Stephens JA; Fernandez SA; Ostrowski MC; Leone G
Oncogene; 2016 Jul; 35(28):3636-46. PubMed ID: 26549026
[TBL] [Abstract][Full Text] [Related]
20. SOCS3 modulates interleukin-6R signaling preference in dermal fibroblasts.
Luckett-Chastain LR; Ihnat MA; Mickle-Kawar BM; Gallucci RM
J Interferon Cytokine Res; 2012 May; 32(5):207-15. PubMed ID: 22313262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
